Vaccination within teratogenic window not linked to presence of congenital anomalies identified on ultrasonography
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy
No Adverse Outcomes Seen With SARS-CoV-2 Vaccination in Pregnancy
No significantly increased risk reported for preterm birth, stillbirth, SGA, low Apgar score, or neonatal care admission
COVID-19 Vaccination Safe During Pregnancy
No differences seen in neonatal and early infant outcomes for offspring exposed, not exposed to vaccine in utero
Risk for Maternal Morbidity, Death Up With SARS-CoV-2 Infection
Moderate or more severe COVID-19 linked to primary outcome while mild, asymptomatic infection was not
Vaccination in Pregnancy Prevents COVID-19 Hospitalization in Infants
Maternal completion of two-dose primary mRNA COVID-19 vaccination series 61 percent effective for preventing COVID-19 hospitalization
Antibodies Persist for Infants Born to COVID-19-Vaccinated Moms
Anti-spike antibody levels lower in infants born to mothers who were infected with SARS-CoV-2 at 20 to 32 weeks of gestation
Extensive Placental Damage ID’d in COVID-19-Linked Stillbirths
Mechanism of stillbirth, neonatal death is hypoxic-ischemic injury resulting from placental destruction and insufficiency caused by SARS-CoV-2
COVID-19 mRNA Vaccination Does Not Impair IVF Outcomes
No association seen between vaccine administration and fertilization rates or early pregnancy outcomes
One-Third of Pregnant Women Report Mental Distress During Pandemic
Health behavior impacts showed a dose-response relationship with mental health distress